Ventas, Inc. Announces Executive Retirement and Updates ATM Sales Agreement

Summary

On May 12, 2026, Ventas, Inc. announced the retirement of Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, who will receive a prorated 2026 bonus as part of his separation agreement. The company also held its 2026 Annual Meeting of Stockholders on May 13, 2026, where all 12 director nominees were elected, the compensation of Named Executive Officers was approved on an advisory basis, and KPMG LLP was ratified as the independent registered public accounting firm for the 2026 fiscal year. Additionally, on May 15, 2026, Ventas, Inc. entered into Amendment No. 3 to its ATM Sales Agreement, increasing the aggregate gross sales price of common stock available for issuance under the agreement to $3,000,000,000.